10% Owner, Odyssey Health, Inc. sold 5,044 shares of Oragenics Inc [OGEN]

In a filing, Oragenics Inc revealed its 10% Owner Odyssey Health, Inc. unloaded Company’s shares for reported $21487.0 on Jun 18 ’25. In the deal valued at $4.26 per share,5,044 shares were sold. As a result of this transaction, Odyssey Health, Inc. now holds 0 shares worth roughly $0.0.

Then, Odyssey Health, Inc. sold 2,000 shares, generating $8,920 in total proceeds. Upon selling the shares at $4.46, the 10% Owner now owns 5,044 shares.

Before that, Odyssey Health, Inc. sold 5,000 shares. Oragenics Inc shares valued at $22,250 were divested by the 10% Owner at a price of $4.45 per share. As a result of the transaction, Odyssey Health, Inc. now holds 7,044 shares, worth roughly $10918.2.

Price Performance Review of OGEN

On Tuesday, Oragenics Inc [AMEX:OGEN] saw its stock fall -59.42% to $1.55. Over the last five days, the stock has lost -57.06%. Oragenics Inc shares have fallen nearly -94.78% since the year began. Nevertheless, the stocks have fallen -86.01% over the past one year. While a 52-week high of $75.60 was reached on 02/05/25, a 52-week low of $3.12 was recorded on 07/01/25.

Levels Of Support And Resistance For OGEN Stock

The 24-hour chart illustrates a support level at 1.46, which if violated will result in even more drops to 1.37. On the upside, there is a resistance level at 1.72. A further resistance level may holdings at 1.89.

How much short interest is there in Oragenics Inc?

A steep rise in short interest was recorded in Oragenics Inc stocks on 2025-06-13, growing by 0.26 million shares to a total of 0.29 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 29708.0 shares. There was a rise of 89.74%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.